59/120
2.5 / 5 stars
All 120 Win/Lose results shown below
LH Roast Me summary
LABCORP HOLDINGS INC. (LH). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLH / S&P 5.23% / 15.20% |
LoseLH / S&P 6.41% / 15.00% |
LoseLH / S&P 33.30% / 50.40% |
| 2026-Q12/3 |
WinLH / S&P 6.62% / -4.33% |
LoseLH / S&P 7.34% / 11.30% |
WinLH / S&P 30.37% / 27.70% |
| 2025-Q41/3 |
LoseLH / S&P -12.37% / 2.65% |
LoseLH / S&P 7.25% / 9.00% |
WinLH / S&P 18.33% / 13.40% |
| 2025-Q33/3 |
WinLH / S&P 9.63% / 8.12% |
WinLH / S&P 8.28% / 4.61% |
WinLH / S&P 93.73% / 13.45% |
| 2025-Q23/3 |
WinLH / S&P 13.12% / 10.94% |
WinLH / S&P 7.98% / 4.83% |
WinLH / S&P 68.90% / 10.63% |
| 2025-Q13/3 |
WinLH / S&P 1.78% / -4.27% |
WinLH / S&P 7.13% / 4.98% |
WinLH / S&P 71.15% / 10.57% |
| 2024-Q43/3 |
WinLH / S&P 2.92% / 2.41% |
WinLH / S&P 6.97% / 5.25% |
WinLH / S&P 85.32% / 6.15% |
| 2024-Q31/3 |
WinLH / S&P 10.16% / 5.89% |
LoseLH / S&P 5.43% / 5.89% |
LoseLH / S&P -30.52% / 6.11% |
| 2024-Q20/3 |
LoseLH / S&P -6.50% / 4.28% |
LoseLH / S&P 5.22% / 5.38% |
LoseLH / S&P -42.63% / 5.12% |
| 2024-Q10/3 |
LoseLH / S&P -3.57% / 10.56% |
LoseLH / S&P 4.62% / 5.71% |
LoseLH / S&P -54.46% / 5.59% |
| 2023-Q41/3 |
WinLH / S&P 13.44% / 11.69% |
LoseLH / S&P 2.51% / 6.81% |
LoseLH / S&P -65.86% / 7.78% |
| 2023-Q32/3 |
WinLH / S&P -2.70% / -3.27% |
WinLH / S&P 12.06% / 7.52% |
LoseLH / S&P -59.65% / -5.03% |
| 2023-Q20/3 |
LoseLH / S&P 5.54% / 8.74% |
LoseLH / S&P -0.74% / 9.50% |
LoseLH / S&P -55.24% / -8.57% |
| 2023-Q10/3 |
LoseLH / S&P -2.29% / 7.50% |
LoseLH / S&P -8.68% / 10.77% |
LoseLH / S&P -49.04% / -15.69% |
| 2022-Q41/3 |
WinLH / S&P 15.31% / 7.56% |
LoseLH / S&P -9.68% / 11.88% |
LoseLH / S&P -42.72% / -17.99% |
| 2022-Q30/3 |
LoseLH / S&P -12.37% / -4.88% |
LoseLH / S&P -35.00% / 13.47% |
LoseLH / S&P -33.48% / -1.41% |
| 2022-Q21/3 |
WinLH / S&P -10.85% / -16.10% |
LoseLH / S&P -27.04% / 13.71% |
LoseLH / S&P -28.68% / 11.04% |
| 2022-Q10/3 |
LoseLH / S&P -16.09% / -4.60% |
LoseLH / S&P -15.94% / 15.97% |
LoseLH / S&P -19.05% / 42.23% |
| 2021-Q41/3 |
WinLH / S&P 11.64% / 11.03% |
LoseLH / S&P -6.03% / 15.00% |
LoseLH / S&P 53.59% / 96.40% |
| 2021-Q33/3 |
WinLH / S&P 2.03% / 0.58% |
WinLH / S&P 33.05% / 10.77% |
WinLH / S&P 228.67% / 69.42% |
| 2021-Q22/3 |
LoseLH / S&P 8.16% / 8.55% |
WinLH / S&P 42.82% / 6.58% |
WinLH / S&P 701.09% / 51.81% |
| 2021-Q13/3 |
WinLH / S&P 25.29% / 6.17% |
WinLH / S&P 32.18% / -1.06% |
WinLH / S&P 736.34% / 7.39% |
| 2020-Q42/3 |
LoseLH / S&P 8.12% / 12.15% |
WinLH / S&P 20.98% / -3.72% |
WinLH / S&P 90.18% / -33.42% |
| 2020-Q33/3 |
WinLH / S&P 13.34% / 8.93% |
WinLH / S&P 9.25% / -2.04% |
WinLH / S&P 12.75% / -27.10% |
| 2020-Q22/3 |
WinLH / S&P 31.43% / 20.54% |
WinLH / S&P 1.62% / -0.46% |
LoseLH / S&P -56.74% / -27.11% |
| 2020-Q10/3 |
LoseLH / S&P -25.29% / -19.60% |
LoseLH / S&P 2.76% / 3.47% |
LoseLH / S&P -63.41% / -14.75% |
| 2019-Q40/3 |
LoseLH / S&P 0.70% / 9.07% |
LoseLH / S&P 1.95% / 5.36% |
LoseLH / S&P -3.02% / 2.99% |
| 2019-Q30/3 |
LoseLH / S&P -2.83% / 1.70% |
LoseLH / S&P 0.87% / 5.02% |
LoseLH / S&P -44.29% / 0.21% |
| 2019-Q21/3 |
WinLH / S&P 13.02% / 4.30% |
LoseLH / S&P 1.90% / 6.64% |
LoseLH / S&P -30.71% / 8.65% |
| 2019-Q11/3 |
WinLH / S&P 21.07% / 13.65% |
LoseLH / S&P 4.97% / 8.12% |
LoseLH / S&P -24.91% / 14.29% |
| 2018-Q41/3 |
LoseLH / S&P -27.25% / -13.52% |
WinLH / S&P 9.95% / 9.05% |
LoseLH / S&P -27.10% / 18.23% |
| 2018-Q32/3 |
LoseLH / S&P -3.26% / 7.71% |
WinLH / S&P 14.01% / 10.21% |
WinLH / S&P 102.37% / 19.06% |
| 2018-Q23/3 |
WinLH / S&P 10.99% / 3.43% |
WinLH / S&P 14.28% / 9.03% |
WinLH / S&P 79.30% / 14.46% |
| 2018-Q13/3 |
WinLH / S&P 1.40% / -0.76% |
WinLH / S&P 11.92% / 7.68% |
WinLH / S&P 67.67% / 12.46% |
| 2017-Q42/3 |
LoseLH / S&P 5.66% / 6.64% |
WinLH / S&P 7.90% / 7.03% |
WinLH / S&P 73.17% / 13.82% |
| 2017-Q30/3 |
LoseLH / S&P -2.06% / 4.48% |
LoseLH / S&P 4.09% / 5.68% |
LoseLH / S&P 6.97% / 17.57% |
| 2017-Q21/3 |
WinLH / S&P 7.44% / 3.09% |
LoseLH / S&P 2.97% / 4.83% |
LoseLH / S&P 11.64% / 17.74% |
| 2017-Q13/3 |
WinLH / S&P 11.75% / 6.07% |
WinLH / S&P 3.71% / 3.67% |
WinLH / S&P 20.52% / 13.32% |
| 2016-Q42/3 |
LoseLH / S&P -6.62% / 3.82% |
WinLH / S&P 10.06% / 2.09% |
WinLH / S&P 56.78% / 7.05% |
| 2016-Q33/3 |
WinLH / S&P 5.53% / 3.85% |
WinLH / S&P 20.55% / 0.20% |
WinLH / S&P 37.77% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | LH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 21.55% | 20.78% |
| Annualized return | 21.55% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | LH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 34.64% | 83.14% |
| Annualized return | 6.13% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | LH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 201.64% | 319.30% |
| Annualized return | 11.67% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |